XNAS · Laboratory Analytical Instruments · S&P 500
$166.18
-$5.30 (-3.09%) today
Open $171.48 High $171.48 Low $164.55 Vol 703K Avg $166.11
Find similar stocks by technical condition — S&P 500 universe
| Symbol | Company Name | Exchange | Currency | Category |
|---|---|---|---|---|
| NEWP | New Pacific Metals Corp. | XASE | USD | - |
| IAG | IAMGold Corporation | XNYS | USD | - |
| BHST | BioHarvest Sciences Inc. Common Stock | XNAS | USD | - |
| BLDP | Ballard Power Systems Inc. | XNAS | USD | - |
| VFS | VinFast Auto Ltd. Ordinary Shares | XNAS | USD | - |
| CHY | Calamos Convertible and High Income Fund | XNAS | USD | - |
| AEC | Anfield Energy Inc. Common Shares | XNAS | USD | - |
| GCDT | Green Circle Decarbonize Technology Limited | XASE | USD | - |
| OXLC | Oxford Lane Capital Corp. | XNAS | USD | - |
| DTSS | Datasea Intelligent Technology Ltd. Class A Ordinary Shares | XNAS | USD | - |
52-week price range
Price is 149.6% above its 52-week low and 21.2% below its 52-week high. Trading in the upper half of its annual range — closer to the peak than the base.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.